SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035386
Filing Date
2024-08-07
Accepted
2024-08-07 07:55:30
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itci-20240630.htm   iXBRL 10-Q 866047
2 EX-31.1 itci-20240630xex311.htm EX-31.1 9620
3 EX-31.2 itci-20240630xex312.htm EX-31.2 9648
4 EX-32 itci-20240630xex32.htm EX-32 5419
  Complete submission text file 0001628280-24-035386.txt   4773033

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20240630.xsd EX-101.SCH 33398
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itci-20240630_cal.xml EX-101.CAL 60154
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20240630_def.xml EX-101.DEF 131207
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20240630_lab.xml EX-101.LAB 488472
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20240630_pre.xml EX-101.PRE 319752
65 EXTRACTED XBRL INSTANCE DOCUMENT itci-20240630_htm.xml XML 570322
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 241181487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)